共 207 条
[1]
Ribas A(2018)Cancer immunotherapy using checkpoint blockade Science 359 1350-1355
[2]
Wolchok JD(2018)Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis BMJ 363 k4226-1728
[3]
Xu C(2018)Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis JAMA Oncol 4 1721-225
[4]
Chen YP(2016)Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Eur J Cancer 60 210-1222
[5]
Du XJ(2017)Neurological complications associated with anti-programmed death 1 (PD-1) antibodies JAMA Neurol 74 1216-8
[6]
Liu JQ(2017)Neurological adverse events associated with immune checkpoint inhibitors: review of the literature Eur J Cancer 73 1-385
[7]
Huang CL(2017)Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature Ann Oncol 28 377-718
[8]
Chen L(2018)Neurological adverse events associated with immune checkpoint inhibitors: diagnosis and management Curr Neurol Neurosci Rep 18 3-136
[9]
Zhou GQ(2018)Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system Ther Adv Neurol Disord 11 1756286418799864-1134
[10]
Li WF(2017)Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis Oncologist 22 709-1390